June 14, 2022Open Access

Diagnostic Performance of Prostate-specific Membrane Antigen Positron Emission Tomography–targeted biopsy for Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis

Key Points

Key points are not available for this paper at this time.

Abstract

Prostate-specific membrane antigen positron emission tomography (PSMA-PET) is a promising imaging method for detecting clinically significant prostate cancer and seems to have additional value to magnetic resonance imaging (MRI) for detection.

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Kawada et al. (Tue,) studied this question.

synapsesocial.com/papers/69d5730d9d980f6498ccb27d https://doi.org/https://doi.org/10.1016/j.euo.2022.04.006

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

168Ga-PSMA 11 ligand PET imaging in patients with biochemical recurrence after radical prostatectomy – diagnostic performance and impact on therapeutic decision-making2017 · 120 citations
2Prostate Specific Membrane Antigen Positron Emission Tomography May Improve the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging in Localized Prostate Cancer2016 · 129 citations
3High level PSMA expression is associated with early psa recurrence in surgically treated prostate cancer2010 · 280 citations
4PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 22015 · 2,937 citations
5Combination of <sup>68</sup>Ga-PSMA PET/CT and Multiparametric MRI Improves the Detection of Clinically Significant Prostate Cancer: A Lesion-by-Lesion Analysis2018 · 130 citations

Bookmark

View Full Paper